Parallax Volatility Advisers’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,700
| Closed | -$944K | – | 1972 |
|
|
2024
Q4 | $944K | Hold |
9,700
| – | – | ﹤0.01% | 1349 |
|
|
2024
Q3 | $1.12M | Sell |
9,700
-20,200
| -68% | -$2.29M | ﹤0.01% | 1330 |
|
|
2024
Q2 | $3.18M | Buy |
+29,900
| New | +$3M | 0.01% | 871 |
|
|
2024
Q1 | – | Sell |
-15,600
| Closed | -$1.58M | – | 2197 |
|
|
2023
Q4 | $1.58M | Sell |
15,600
-9,400
| -38% | -$907K | ﹤0.01% | 1247 |
|
|
2023
Q3 | $2.55M | Sell |
25,000
-4,400
| -15% | -$447K | 0.01% | 1007 |
|
|
2023
Q2 | $2.97M | Sell |
29,400
-102,700
| -78% | -$10.3M | 0.01% | 980 |
|
|
2023
Q1 | $12.2M | Buy |
132,100
+2,600
| +2% | +$227K | 0.02% | 520 |
|
|
2022
Q4 | $11.7M | Sell |
129,500
-113,900
| -47% | -$9.59M | 0.02% | 720 |
|
|
2022
Q3 | $18.5M | Buy |
+243,400
| New | +$20.2M | 0.03% | 535 |
|
|
2022
Q1 | – | Sell |
-34,700
| Closed | -$3.04M | – | 3032 |
|
|
2021
Q4 | $3.04M | Buy |
34,700
+100
| +0.3% | +$8.3K | ﹤0.01% | 945 |
|
|
2021
Q3 | $2.83M | Buy |
+34,600
| New | +$3.11M | ﹤0.01% | 1022 |
|
|
2021
Q1 | – | Sell |
-2,700
| Closed | -$255K | – | 1987 |
|
|
2020
Q4 | $255K | Hold |
2,700
| – | – | ﹤0.01% | 1805 |
|
|
2020
Q3 | $235K | Sell |
2,700
-400
| -13% | -$34.7K | ﹤0.01% | 2487 |
|
|
2020
Q2 | $270K | Sell |
3,100
-12,500
| -80% | -$1.08M | ﹤0.01% | 2164 |
|
|
2020
Q1 | $1.29M | Sell |
15,600
-10,700
| -41% | -$955K | ﹤0.01% | 1397 |
|
|
2019
Q4 | $2.49M | Sell |
26,300
-14,900
| -36% | -$1.34M | ﹤0.01% | 1174 |
|
|
2019
Q3 | $3.58M | Buy |
41,200
+3,400
| +9% | +$305K | ﹤0.01% | 924 |
|
|
2019
Q2 | $3.45M | Buy |
37,800
+12,244
| +48% | +$1.04M | ﹤0.01% | 856 |
|
|
2019
Q1 | $2.2M | Buy |
+25,556
| New | +$2.05M | ﹤0.01% | 966 |
|
|
2018
Q1 | – | Sell |
-29,909
| Closed | -$2.25M | – | 3602 |
|
|
2017
Q4 | $2.25M | Buy |
+29,909
| New | +$2.26M | ﹤0.01% | 883 |
|
|
2017
Q3 | – | Sell |
-5,022
| Closed | -$376K | – | 2866 |
|
|
2017
Q2 | $376K | Buy |
+5,022
| New | +$356K | ﹤0.01% | 1300 |
|
|
2016
Q3 | – | Sell |
-6,808
| Closed | -$503K | – | 3580 |
|
|
2016
Q2 | $503K | Buy |
+6,808
| New | +$470K | ﹤0.01% | 1460 |
|
|
2013
Q4 | – | Sell |
-145,638
| Closed | -$10M | – | 3507 |
|
|
2013
Q3 | $10M | Sell |
145,638
-85,151
| -37% | -$5.63M | 0.05% | 261 |
|
|
2013
Q2 | $14.6M | Buy |
+230,789
| New | +$15M | 0.07% | 216 |
|
Other funds holding NVS
Parallax Volatility Advisers's NVS Position: Q1 2025 in Review
Parallax Volatility Advisers sold out of Novartis (NVS) in Q1 2025, closing a stake of 803 shares — an estimated $78.1K sold.
Parallax Volatility Advisers first reported a position in NVS in Q3 2018 and held it in 12 quarters. The position peaked at $18M in Q1 2019. 1,356 funds tracked by Wall St. Rank hold NVS as of Q1 2025.
- Parallax Volatility Advisers reported no remaining Novartis position as of Q1 2025 after selling out during the quarter.
- Parallax Volatility Advisers sold 803 Novartis shares in Q1 2025, an estimated $78.1K.
- Parallax Volatility Advisers first reported a position in Novartis in Q3 2018 and held it in 12 quarters.
- Parallax Volatility Advisers's Novartis position peaked at $18M in Q1 2019.
- 1,356 funds tracked by Wall St. Rank held Novartis as of Q1 2025.
Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.